TCM Ltd
TCM Ltd (TCMLMTD): company summary
The company's business is shrinking, with annual revenue falling 24.1% to ₹20 crore.
TCM Ltd (TCMLMTD) is a micro-cap Chemicals company valued at ₹36 crore operating in Commodity Chemicals on the NSE and BSE.
- Recent price move
- TCM Ltd last traded at ₹46.5, sharply down 10.23% on the day.
- Recent developments
- 2026-06-30: The company reported a net loss of ₹6 crore for the latest fiscal year, widening from a loss of ₹4 crore in the prior year. 2026-06-30: The latest quarter ended with a net loss of ₹2 crore, matching the previous quarter's loss but showing a narrowing of the loss compared to the year-ago quarter.
- Financial performance
- The company's business is shrinking, with annual revenue falling 24.1% to ₹20 crore. However, the latest quarter saw revenue rise 52.0% year-on-year to ₹5 crore, while net profit remained flat at a loss of ₹2 crore. Margins have deteriorated sharply, with net profit margin plunging 35.7 percentage points to -30.3%, and returns are negative across the board.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 1.41 times book value.
- Things to watch
- The company is currently in a net loss, with a net profit margin of -30.3%. Returns on equity and capital employed are both negative, indicating poor profitability. The stock is 36.0% below its 52-week high, and the company has reported a widening loss in the latest financial year.
- Where it stands
- The company is struggling with profitability, reporting a net loss of ₹6 crore for the latest fiscal year, while revenue growth has slowed significantly. The latest quarter showed some improvement, with revenue rising 52.0% year-on-year, but net profit remained flat at a loss. The stock is 36.0% below its 52-week high.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by growth (7.5) and valuation (6.0), but held back by quality (0.0). Growth looks strong at 7.5, but that is offset by quality at 0.0 and momentum at 1.1. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Revenue compounding 36% a year
- Loss-making — no meaningful P/E
- Loss-making in some of the last 5 years
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Chemicals stocks · Commodity Chemicals
Explore TCM Ltd’s valuation
Free deep-dive tools · no sign-up
TCM Ltd peers in Chemicals
Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.
Related tools & concepts
Value TCM Ltd with the ratios and calculators DocStoX uses in its analysis.

